YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine.
Bozdayi AM, Uzunalimoğlu O, Türkyilmaz AR, Aslan N, Sezgin O, Sahin T, Bozdayi G, Cinar K, Pai SB, Pai R, Bozkaya H, Karayalçin S, Yurdaydin C, Schinazi RF.
Bozdayi AM, et al. Among authors: cinar k.
J Viral Hepat. 2003 Jul;10(4):256-65. doi: 10.1046/j.1365-2893.2003.00435.x.
J Viral Hepat. 2003.
PMID: 12823591
Clinical Trial.